Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

2.0K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.0K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

2.9K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.9K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gephyrin Neurological Autoimmunity.

Annals of neurology·2026
Same author

Septin multimer autoantibodies in severe motor neuropathy mimicking lower motor neuron disease.

Brain : a journal of neurology·2026
Same author

AEGIS reveals epitope- and clone-resolved convergence of CNS B and T cell autoreactivity in ROHHAD.

bioRxiv : the preprint server for biology·2026
Same author

Long-Term Outcomes in Stiff Person Spectrum Disorder.

European journal of neurology·2026
Same author

Novel methods for neural IgG characterization and validation in autoimmune neurologic disorders.

Journal of immunological methods·2026
Same author

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice.

Annals of clinical and translational neurology·2026

Related Experiment Video

Updated: Mar 9, 2026

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

GAD65 neurological autoimmunity.

Andrew McKeon1,2, Jennifer A Tracy1

  • 1Department of Neurology, College of Medicine, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota, 55905, USA.

Muscle & Nerve
|January 8, 2017
PubMed
Summary
This summary is machine-generated.

Glutamic acid decarboxylase 65 (GAD65) antibodies are key biomarkers for autoimmune neurological and non-neurological diseases. Recognizing GAD65 autoimmunity aids in identifying associated conditions and predicting immunotherapy response.

Keywords:
GAD65ataxiaautoimmuneneurologicalstiff-person

More Related Videos

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

12.1K
Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

84.2K

Related Experiment Videos

Last Updated: Mar 9, 2026

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

12.1K
Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

84.2K

Area of Science:

  • Neuroimmunology
  • Autoimmune Disorders

Background:

  • Glutamic acid decarboxylase 65-kilodalton isoform (GAD65) antibodies are established biomarkers.
  • They are associated with both central nervous system (CNS) autoimmune disorders and nonneurological autoimmune diseases.
  • Commonly associated non-neurological conditions include type 1 diabetes, autoimmune thyroid disease, and pernicious anemia.

Purpose of the Study:

  • To review the significance of GAD65 autoimmunity.
  • To discuss the spectrum of neurological phenotypes associated with GAD65 antibodies.
  • To highlight the importance of recognizing GAD65 autoimmunity for patient management.

Main Methods:

  • Literature review of studies on GAD65 antibodies and associated autoimmune conditions.
  • Analysis of neurological phenotypes and their relation to GAD65 autoimmunity.
  • Evaluation of immunotherapy response in GAD65-associated disorders.

Main Results:

  • Approximately 70% of patients with GAD65 neurological autoimmunity have coexisting non-neurological autoimmune disorders.
  • Neurological phenotypes include limbic encephalitis, epilepsy, cerebellar ataxia, and stiff-person syndrome (SPS).
  • Immunotherapy response is variable, with about 50% of patients showing improvement.

Conclusions:

  • GAD65 autoimmunity is crucial for identifying coexisting non-neurological autoimmune diseases.
  • Recognition of GAD65 autoimmunity is important for predicting potential immunotherapy response.
  • Understanding the diverse phenotypes associated with GAD65 antibodies aids in diagnosis and management.